PPARs and the Placenta

Placenta

Volumn 28, Issue 2-3, 2007, Pages 65-76

  Fournier, T ^a,b   Tsatsaris, V ^a,b,c   Handschuh, K ^a,b   Evain Brion, D ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Université René Descartes Paris 5 ^*  (France)

Author keywords

Cytotrophoblast; Differentiation; Placenta; PPAR

Indexed keywords

CHORIONIC GONADOTROPIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CYTOTROPHOBLAST; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LIGAND BINDING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

ANIMALS; FEMALE; GENE EXPRESSION; HUMANS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLACENTA; PREGNANCY; TROPHOBLASTS;

EID: 33845576118     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.04.009     Document Type: Article

References (113)

1. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
2. Laudet V., Hanni C., Coll J., Catzeflis F., and Stehelin D. Evolution of the nuclear receptor gene superfamily. EMBO J 11 (1992) 1003-1013
3. Chinetti-Gbaguidi G., Fruchart J.C., and Staels B. Pleiotropic effects of fibrates. Curr Atheroscler Rep 7 (2005) 396-401
4. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
5. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
6. Sher T., Yi H.F., McBride O.W., and Gonzalez F.J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32 (1993) 5598-5604
7. Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K., et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4 (1995) 281-299
8. Jones P.S., Savory R., Barratt P., Bell A.R., Gray T.J., Jenkins N.A., et al. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur J Biochem 233 (1995) 219-226
9. Yoshikawa T., Brkanac Z., Dupont B.R., Xing G.Q., Leach R.J., and Detera-Wadleigh S.D. Assignment of the human nuclear hormone receptor, NUC1 (PPARD), to chromosome 6p21.1-p21.2. Genomics 35 (1996) 637-638
10. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272 (1997) 18779-18789
11. Zhu Y., Qi C., Korenberg J.R., Chen X.N., Noya D., Rao M.S., et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92 (1995) 7921-7925
12. Yen C.J., Beamer B.A., Negri C., Silver K., Brown K.A., Yarnall D.P., et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241 (1997) 270-274
13. Krey G., Keller H., Mahfoudi A., Medin J., Ozato K., Dreyer C., et al. Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J Steroid Biochem Mol Biol 47 (1993) 65-73
14. Gearing K.L., Crickmore A., and Gustafsson J.A. Structure of the mouse peroxisome proliferator activated receptor alpha gene. Biochem Biophys Res Commun 199 (1994) 255-263
15. Green S., and Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4 (1988) 309-314
16. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
17. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
18. IJpenberg A., Jeannin E., Wahli W., and Desvergne B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J Biol Chem 272 (1997) 20108-20117
19. Hsu M.H., Palmer C.N., Song W., Griffin K.J., and Johnson E.F. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J Biol Chem 273 (1998) 27988-27997
20. Gervois P., Torra I.P., Chinetti G., Grotzinger T., Dubois G., Fruchart J.C., et al. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol Endocrinol 13 (1999) 1535-1549
21. Gray J.P., Davis II J.W., Gopinathan L.G., Leas T.L., Nugent C.A., and Vanden Heuvel J.P. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-{alpha}. Toxicol Sci (2005)
22. Gray J.P., Burns K.A., Leas T.L., Perdew G.H., and Vanden Heuvel J.P. Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C. Biochemistry 44 (2005) 10313-10321
23. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
24. Sumanasekera W.K., Tien E.S., Davis II J.W., Turpey R., Perdew G.H., and Vanden Heuvel J.P. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 42 (2003) 10726-10735
25. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11 (1997) 779-791
26. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A 94 (1997) 4318-4323
27. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., and Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
28. Gupta R.A., Tan J., Krause W.F., Geraci M.W., Willson T.M., Dey S.K., et al. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci U S A 97 (2000) 13275-13280
29. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
30. Nagy L., Tontonoz P., Alvarez J.G., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93 (1998) 229-240
31. Davies S.S., Pontsler A.V., Marathe G.K., Harrison K.A., Murphy R.C., Hinshaw J.C., et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 276 (2001) 16015-16023
32. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272 (1997) 3406-3410
33. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270 (1995) 12953-12956
34. Tontonoz P., Singer S., Forman B.M., Sarraf P., Fletcher J.A., Fletcher C.D., et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 94 (1997) 237-241
35. Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Bergera J., et al. Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett 473 (2000) 333-336
36. Oliver Jr. W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98 (2001) 5306-5311
37. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 53 (2002) 409-435
38. Tan N.S., Michalik L., Desvergne B., and Wahli W. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes. J Steroid Biochem Mol Biol 93 (2005) 99-105
39. Mukherjee R., Jow L., Croston G.E., and Paterniti Jr. J.R. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272 (1997) 8071-8076
40. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 (1998) 137-143
41. Kodera Y., Takeyama K., Murayama A., Suzawa M., Masuhiro Y., and Kato S. Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators. J Biol Chem 275 (2000) 33201-33204
42. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., and Roeder R.G. The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci U S A 95 (1998) 7939-7944
43. Zhu Y., Kan L., Qi C., Kanwar Y.S., Yeldandi A.V., Rao M.S., et al. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem 275 (2000) 13510-13516
44. Puigserver P., Adelmant G., Wu Z., Fan M., Xu J., O'Malley B., et al. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 286 (1999) 1368-1371
45. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., and O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279 (1998) 1922-1925
46. Treuter E., Albrektsen T., Johansson L., Leers J., and Gustafsson J.A. A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 12 (1998) 864-881
47. Jow L., and Mukherjee R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors. J Biol Chem 270 (1995) 3836-3840
48. Juge-Aubry C., Pernin A., Favez T., Burger A.G., Wahli W., Meier C.A., et al. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J Biol Chem 272 (1997) 25252-25259
49. Miyata K.S., Zhang B., Marcus S.L., Capone J.P., and Rachubinski R.A. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling. J Biol Chem 268 (1993) 19169-19172
50. Baes M., Castelein H., Desmet L., and Declercq P.E. Antagonism of COUP-TF and PPAR alpha/RXR alpha on the activation of the malic enzyme gene promoter: modulation by 9-cis RA. Biochem Biophys Res Commun 215 (1995) 338-345
51. IJpenberg A., Tan N.S., Gelman L., Kersten S., Seydoux J., Xu J., et al. In vivo activation of PPAR target genes by RXR homodimers. EMBO J 23 (2004) 2083-2091
52. Shalev A., Siegrist-Kaiser C.A., Yen P.M., Wahli W., Burger A.G., Chin W.W., et al. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137 (1996) 4499-4502
53. Juge-Aubry C.E., Hammar E., Siegrist-Kaiser C., Pernin A., Takeshita A., Chin W.W., et al. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 274 (1999) 10505-10510
54. Hu E., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274 (1996) 2100-2103
55. Camp H.S., and Tafuri S.R. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 272 (1997) 10811-10816
56. Adams M., Montague C.T., Prins J.B., Holder J.C., Smith S.A., Sanders L., et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100 (1997) 3149-3153
57. Wang L.H., Yang X.Y., Zhang X., Huang J., Hou J., Li J., et al. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. Immunity 20 (2004) 205-218
58. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., et al. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302 (2003) 453-457
59. Genolet R., Wahli W., and Michalik L. PPARs as drug targets to modulate inflammatory responses?. Curr Drug Targets Inflamm Allergy 3 (2004) 361-375
60. Delerive P., De Bosscher K., Vanden Berghe W., Fruchart J.C., Haegeman G., and Staels B. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol 16 (2002) 1029-1039
61. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005) 759-763
62. Matsuo H., and Strauss III J.F. Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function. Endocrinology 135 (1994) 1135-1145
63. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4 (1999) 597-609
64. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585-595
65. Wang Q., Fujii H., and Knipp G.T. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta 23 (2002) 661-671
66. Asami-Miyagishi R., Iseki S., Usui M., Uchida K., Kubo H., and Morita I. Expression and function of PPARgamma in rat placental development. Biochem Biophys Res Commun 315 (2004) 497-501
67. Waite L.L., Person E.C., Zhou Y., Lim K.H., Scanlan T.S., and Taylor R.N. Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab 85 (2000) 3808-3814
68. Tarrade A., Schoonjans K., Pavan L., Auwerx J., Rochette-Egly C., Evain-Brion D., et al. PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86 (2001) 5017-5024
69. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
70. Daoud G., Simoneau L., Masse A., Rassart E., and Lafond J. Expression of cFABP and PPAR in trophoblast cells: effect of PPAR ligands on linoleic acid uptake and differentiation. Biochim Biophys Acta 1687 (2005) 181-194
71. Sapin V., Dolle P., Hindelang C., Kastner P., and Chambon P. Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses. Dev Biol 191 (1997) 29-41
72. Wendling O., Chambon P., and Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci U S A 96 (1999) 547-551
73. Zhu Y., Qi C., Jia Y., Nye J.S., Rao M.S., and Reddy J.K. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J Biol Chem 275 (2000) 14779-14782
74. Crawford S.E., Qi C., Misra P., Stellmach V., Rao M.S., Engel J.D., et al. Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J Biol Chem 277 (2002) 3585-3592
75. Ma G.T., Roth M.E., Groskopf J.C., Tsai F.Y., Orkin S.H., Grosveld F., et al. GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. Development 124 (1997) 907-914
76. Zhu Y.J., Crawford S.E., Stellmach V., Dwivedi R.S., Rao M.S., Gonzalez F.J., et al. Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J Biol Chem 278 (2003) 1986-1990
77. Antonson P., Schuster G.U., Wang L., Rozell B., Holter E., Flodby P., et al. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol Cell Biol 23 (2003) 1260-1268
78. Hewitt D.P., Mark P.J., and Waddell B.J. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure. Biol Reprod 74 (2006) 23-28
79. Shalom-Barak T., Nicholas J.M., Wang Y., Zhang X., Ong E.S., Young T.H., et al. Peroxisome proliferator-activated receptor gamma controls Muc1 transcription in trophoblasts. Mol Cell Biol 24 (2004) 10661-10669
80. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 99 (2002) 303-308
81. Michalik L., Desvergne B., Dreyer C., Gavillet M., Laurini R.N., and Wahli W. PPAR expression and function during vertebrate development. Int J Dev Biol 46 (2002) 105-114
82. Schaiff W.T., Carlson M.G., Smith S.D., Levy R., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 85 (2000) 3874-3881
83. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., and Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93 (1998) 241-252
84. Lefebvre M., Paulweber B., Fajas L., Woods J., McCrary C., Colombel J.F., et al. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 162 (1999) 331-340
85. Tarrade A., Schoonjans K., Guibourdenche J., Bidart J.M., Vidaud M., Auwerx J., et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 142 (2001) 4504-4514
86. Cronier L., Bastide B., Herve J.C., Deleze J., and Malassine A. Gap junctional communication during human trophoblast differentiation: influence of human chorionic gonadotropin. Endocrinology 135 (1994) 402-408
87. Shi Q.J., Lei Z.M., Rao C.V., and Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 132 (1993) 1387-1395
88. Martin G., Schoonjans K., Lefebvre A.M., Staels B., and Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 272 (1997) 28210-28217
89. Martin G., Poirier H., Hennuyer N., Crombie D., Fruchart J.C., Heyman R.A., et al. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J Biol Chem 275 (2000) 12612-12618
90. Schaiff W.T., Bildirici I., Cheong M., Chern P.L., Nelson D.M., and Sadovsky Y. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 90 (2005) 4267-4275
91. Bildirici I., Roh C.R., Schaiff W.T., Lewkowski B.M., Nelson D.M., and Sadovsky Y. The lipid droplet-associated protein adipophilin is expressed in human trophoblasts and is regulated by peroxisomal proliferator-activated receptor-gamma/retinoid X receptor. J Clin Endocrinol Metab 88 (2003) 6056-6062
92. Julan L., Guan H., van Beek J.P., and Yang K. Peroxisome proliferator-activated receptor delta suppresses 11beta-hydroxysteroid dehydrogenase type 2 gene expression in human placental trophoblast cells. Endocrinology 146 (2005) 1482-1490
93. Seckl J.R. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Mol Cell Endocrinol 185 (2001) 61-71
94. Pavan L., Tarrade A., Hermouet A., Delouis C., Titeux M., Vidaud M., et al. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. Carcinogenesis 24 (2003) 1325-1336
95. Schild R.L., Schaiff W.T., Carlson M.G., Cronbach E.J., Nelson D.M., and Sadovsky Y. The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metab 87 (2002) 1105-1110
96. Frendo J.L., Olivier D., Cheynet V., Blond J.L., Bouton O., Vidaud M., et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23 (2003) 3566-3574
97. Pavan L., Tsatsaris V., Hermouet A., Therond P., Evain-Brion D., and Fournier T. Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. J Clin Endocrinol Metab 89 (2004) 1969-1972
98. Pavan L., Hermouet A., Tsatsaris V., Therond P., Sawamura T., Evain-Brion D., et al. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145 (2004) 4583-4591
99. Sattar N., Greer I.A., Louden J., Lindsay G., McConnell M., Shepherd J., et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab 82 (1997) 2483-2491
100. Winkler K., Wetzka B., Hoffmann M.M., Friedrich I., Kinner M., Baumstark M.W., et al. Low density lipoprotein (LDL) subfractions during pregnancy: accumulation of buoyant LDL with advancing gestation. J Clin Endocrinol Metab 85 (2000) 4543-4550
101. Wahli W., Devchand P.R., Ijpenberg A., and Desvergne B. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. Adv Exp Med Biol 447 (1999) 199-209
102. Capparuccia L., Marzioni D., Giordano A., Fazioli F., De Nictolis M., Busso N., et al. PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma. Mol Hum Reprod 8 (2002) 574-579
103. Rodie V.A., Young A., Jordan F., Sattar N., Greer I.A., and Freeman D.J. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Invest 12 (2005) 320-329
104. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 (1989) 1200-1204
105. Branch D.W., Mitchell M.D., Miller E., Palinski W., and Witztum J.L. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 343 (1994) 645-646
106. Johnson R.D., Polakoski K.L., Huang X., Sadovsky Y., and Nelson D.M. The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia. Am J Obstet Gynecol 178 (1998) 54-58
107. Malassine A., Frendo J.L., and Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9 (2003) 531-539 (review)
108. Xu Y., Cook T.J., and Knipp G.T. Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicol Sci 84 (2005) 287-300
109. Pidoux G., Gerbaud P., Laurendeau I., Guibourdenche J., Bertin G., Vidaud M., et al. Large variability of trophoblast gene expression within and between human normal term placentae. Placenta 25 (2004) 469-473
110. Marvin K.W., Eykholt R.L., Keelan J.A., Sato T.A., and Mitchell M.D. The 15-deoxy-delta(12, 14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 21 (2000) 436-440
111. Miles J.R., Farin C.E., Rodriguez K.F., Alexander J.E., and Farin P.W. Angiogenesis and morphometry of bovine placentas in late gestation from embryos produced in vivo or in vitro. Biol Reprod 71 (2004) 1919-1926
112. Hashimoto F., Oguchi Y., Morita M., Matsuoka K., Takeda S., Kimura M., et al. PPARalpha agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and up-regulate progesteroS200ne secretions in immortalized human trophoblast cells. Biochem Pharmacol 68 (2004) 313-321
113. Nadra K., Anghel S.I., Joye E., Tan N.S., Basu-Modak S., Trono D., et al. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Mol Cell Biol 26 (2006) 3266-3281